AU8710691A - Ibuprofen-diuretic combinations - Google Patents
Ibuprofen-diuretic combinationsInfo
- Publication number
- AU8710691A AU8710691A AU87106/91A AU8710691A AU8710691A AU 8710691 A AU8710691 A AU 8710691A AU 87106/91 A AU87106/91 A AU 87106/91A AU 8710691 A AU8710691 A AU 8710691A AU 8710691 A AU8710691 A AU 8710691A
- Authority
- AU
- Australia
- Prior art keywords
- ibuprofen
- diuretic combinations
- diuretic
- combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58924290A | 1990-09-28 | 1990-09-28 | |
US589242 | 2000-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8710691A true AU8710691A (en) | 1992-04-28 |
Family
ID=24357215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU87106/91A Abandoned AU8710691A (en) | 1990-09-28 | 1991-09-25 | Ibuprofen-diuretic combinations |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0550689A1 (de) |
JP (1) | JPH06501475A (de) |
AU (1) | AU8710691A (de) |
CA (1) | CA2092565A1 (de) |
WO (1) | WO1992005786A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5462950A (en) * | 1993-12-21 | 1995-10-31 | Eli Lilly And Company | Methods of treating menstrual symptoms and compositions therefore |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
EP2847175A4 (de) * | 2012-05-08 | 2016-04-20 | Cellix Bio Private Ltd | Zusammensetzungen und verfahren zur unterdrückung von carboanhydraseaktivität |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4888343A (en) * | 1986-09-15 | 1989-12-19 | Bristol-Myers Company | Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process |
ATE50493T1 (de) * | 1986-11-14 | 1990-03-15 | Puetter Medice Chem Pharm | Ibuprofen enthaltendes arzneimittel. |
US4851444A (en) * | 1987-07-10 | 1989-07-25 | Analgesic Associates | Onset-hastened/enhanced analgesia |
-
1991
- 1991-09-25 EP EP91919392A patent/EP0550689A1/de not_active Withdrawn
- 1991-09-25 AU AU87106/91A patent/AU8710691A/en not_active Abandoned
- 1991-09-25 JP JP3516780A patent/JPH06501475A/ja active Pending
- 1991-09-25 WO PCT/US1991/007008 patent/WO1992005786A1/en not_active Application Discontinuation
- 1991-09-25 CA CA002092565A patent/CA2092565A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0550689A4 (de) | 1994-02-16 |
WO1992005786A1 (en) | 1992-04-16 |
JPH06501475A (ja) | 1994-02-17 |
EP0550689A1 (de) | 1993-07-14 |
CA2092565A1 (en) | 1992-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU639126B2 (en) | Oxorapamycin | |
AU8791591A (en) | Tnf-muteins | |
AU7846991A (en) | Aminobenzodiazepines | |
AU7867491A (en) | Compounds | |
AU8764191A (en) | Ibuprofen-antihistamine combinations | |
AU7956191A (en) | Transportsystem | |
AU7804691A (en) | N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas | |
AU9030991A (en) | Improved capacitor-sensor | |
AU1556892A (en) | 2-substituted-2-imidazolines | |
AU1080292A (en) | Ige-receptor-antibodies | |
AU7726391A (en) | Slitterscorer | |
AU8017991A (en) | Structural elements | |
AU1766292A (en) | Ibuprofen-decongestant combinations | |
AU6531090A (en) | Swagable fitting | |
AU8624791A (en) | Compounds | |
AU6498390A (en) | Improved packerhead assembly | |
AU7566691A (en) | Compostor | |
AU8740291A (en) | 3d-spectacles | |
AU7587991A (en) | Electrodermatome | |
AU8984191A (en) | Thiadiazinones | |
AU8516291A (en) | Instant photograph-postcard | |
AU7752291A (en) | Stay | |
AU7709991A (en) | Phenoxyphenylsulphonyl compounds | |
AU8710691A (en) | Ibuprofen-diuretic combinations | |
AU7922191A (en) | 2-acylamino-7-chlorobenzothiazoles |